Healthcare -
Biotechnology - NASDAQ - US
$ 103.32
-3.21 %
$ 9.87 B
Market Cap
44.15
P/E
SRPT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SRPT - Sarepta Therapeutics, Inc.
125 M
LAST VALUE
-52.82%
2 YEAR CAGR
-25.10%
5 YEAR CAGR
-1.52%
10 YEAR CAGR